TICKERNOMICS Sign up
Last Update: 2024-12-27 15:29:01
BioSig Technologies Inc. ( BSGM ) https://www.biosig.com
1.43USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-69.84%
BSGM
SPY
32.66%
-94.02%
BSGM
SPY
108.59%
-97.57%
BSGM
SPY
302.52%
-97.95%
BSGM
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
21.81
21.44
0.10
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-1.43
545.32
-77.08
-140.96
0.00
-1.48
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-22692.31
-578.57
-27245.28
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
7.4112
3511.28
1512.04
0.84
Other Earnings and Cash Flow Stats:
BioSig Technologies Inc. ( BSGM ) Net Income TTM ($MM) is -15.28
BioSig Technologies Inc. ( BSGM ) Operating Income TTM ($MM) is -17.85
BioSig Technologies Inc. ( BSGM ) Owners' Earnings Annual ($MM) is 0.00
BioSig Technologies Inc. ( BSGM ) Current Price to Owners' Earnings ratio is 0.00
BioSig Technologies Inc. ( BSGM ) EBITDA TTM ($MM) is -17.59
BioSig Technologies Inc. ( BSGM ) EBITDA Margin is -27245.28%
Capital Allocation:
BioSig Technologies Inc. ( BSGM ) has paid 0.00 dividends per share and bought back -8.741109 million shares in the past 12 months
BioSig Technologies Inc. ( BSGM ) has reduced its debt by 0.25 million USD in the last 12 months
Capital Structure:
BioSig Technologies Inc. ( BSGM ) Interest-bearing Debt ($MM) as of last quarter is 0
BioSig Technologies Inc. ( BSGM ) Annual Working Capital Investments ($MM) are 0
BioSig Technologies Inc. ( BSGM ) Book Value ($MM) as of last quarter is -1
BioSig Technologies Inc. ( BSGM ) Debt/Capital as of last quarter is -4700%
Other Balance Sheet Stats:
BioSig Technologies Inc. ( BSGM ) has 0 million in cash on hand as of last quarter
BioSig Technologies Inc. ( BSGM ) has 1 million of liabilities due within 12 months, and long term debt 0 as of last quarter
BioSig Technologies Inc. ( BSGM ) has 16 common shares outstanding as of last quarter
BioSig Technologies Inc. ( BSGM ) has 0 million USD of preferred stock value
Academic Scores:
BioSig Technologies Inc. ( BSGM ) Altman Z-Score is -278.05 as of last quarter
BioSig Technologies Inc. ( BSGM ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
BioSig Technologies Inc. ( BSGM ) largest shareholder is Virtu Financial LLC owning 11782 shares at 0.02 ($MM) value
Kenneth L Londoner(an insider) Bought 600 shares of BioSig Technologies Inc. ( BSGM ) for the amount of $7020.00 on 2023-06-12
30.77% of BioSig Technologies Inc. ( BSGM ) is held by insiders, and 1.32% is held by institutions
BioSig Technologies Inc. ( BSGM ) went public on 2014-10-30
Other BioSig Technologies Inc. ( BSGM ) financial metrics:
FCF:-7.24
Unlevered Free Cash Flow:-24.73
EPS:-0.47
Operating Margin:-22692.31
Gross Profit Margin:-578.57
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:1890.37
Beta:0.84
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About BioSig Technologies Inc. ( BSGM ) :
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.